Ambrilia Biopharma Inc. Reports Issuance Of U.S. Patent On PCK3145, Its Lead Drug Candidate For Advanced Metastatic Prostate Cancer

May 30, 2006 |

1 min read

U.S. Patent No. 7053058 covers the Signal Transduction Inhibitor PCK3145 and related sequences.